Vascular Responses at Proximal and Distal Edges of Paclitaxel-Eluting Stents: Serial Intravascular Ultrasound Analysis from the TAXUS II Trial

Patrick W. Serruys, Muzaffer Degertekin, Kengo Tanabe, Mary E. Russell, Giulio Guagliumi, John Webb, Jaap Hamburger, Wolfgang Rutsch, Christoph Kaiser, Robert Whitboum, Edoardo Camenzind, Ian Meredith, Fraņois Reeves, Christoph Nienaber, Edouard Benit, Clemens Disco, Jörg Koglin, Antonio Colombo

Research output: Contribution to journalArticle

Abstract

Background-On the basis of brachytherapy experience, edge stenosis has been raised as a potential limitation for drug-eluting stents. We used serial intravascular ultrasound (IVUS) to prospectively analyze vessel responses in adjacent reference segments after implantation of polymer-controlled paclitaxel-eluting stents. Methods and Results-TAXUS II was a randomized, double-blind trial with 2 consecutive patient cohorts that compared slow-release (SR) and moderate-release (MR) paclitaxel-eluting stents with control bare metal stents (BMS). By protocol, all patients had postprocedure and 6-month follow-up IVUS. Quantitative IVUS analysis was performed by an independent core laboratory, blinded to treatment allocation, in 5-mm vessel segments immediately proximal and distal to the stent. Serial IVUS was available for 106 SR, 107 MR, and 214 BMS patients. For all 3 groups, a significant decrease in proximal-edge lumen area was observed at 6 months. The decrease was comparable (by ANOVA, P = 0.194) for patients in the SR (-0.54±2.1 mm2) and MR (-0.88±1.9 mm2) groups compared with the BMS (-1.02±1.9 mm2) group. For the distal edge, a significant decrease in lumen area was only observed with BMS (-0.91±2.0 mm2, P2) and MR (-0.19±1.7 mm2) stents (P2, P=0.011) but not the distal edges of BMS and at neither edge of SR or MR stents. Conclusions-The marked reduction in in-stent restenosis with SR or MR stents is not associated with increased edge stenosis at 6-month follow-up IVUS. In fact, compared with BMS, there is instead a significant reduction in late lumen loss at the distal edge with TAXUS stents.

Original languageEnglish
Pages (from-to)627-633
Number of pages7
JournalCirculation
Volume109
Issue number5
DOIs
Publication statusPublished - Feb 10 2004

Keywords

  • Angioplasty
  • Drugs
  • Stents
  • Ultrasonics

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Vascular Responses at Proximal and Distal Edges of Paclitaxel-Eluting Stents: Serial Intravascular Ultrasound Analysis from the TAXUS II Trial'. Together they form a unique fingerprint.

  • Cite this

    Serruys, P. W., Degertekin, M., Tanabe, K., Russell, M. E., Guagliumi, G., Webb, J., Hamburger, J., Rutsch, W., Kaiser, C., Whitboum, R., Camenzind, E., Meredith, I., Reeves, F., Nienaber, C., Benit, E., Disco, C., Koglin, J., & Colombo, A. (2004). Vascular Responses at Proximal and Distal Edges of Paclitaxel-Eluting Stents: Serial Intravascular Ultrasound Analysis from the TAXUS II Trial. Circulation, 109(5), 627-633. https://doi.org/10.1161/01.CIR.0000112566.87022.32